Cardiometabolic Syndrome Response to Therapeutic Lifestyle Changes

Status unconfirmed · Not applicable

Conditions studied: Metabolic Syndrome, ASCVD, Lifestyle Risk Reduction

In brief

Intensive lifestyle intervention has shown to be effective in high risk patient populations and has gathered support from leaders-as outlined in the 2015 consensus paper by the Cardiometabolic Health Alliance. Thus there has been a call to establish new care models that assist Metabolic Syndrome patients in reducing there risk. The investigators aim to evaluate the impact of a lifestyle intervention program on metabolic syndrome patients.

Key facts

Study ID

NCT04093440

Run by

Holy Cross Hospital, Florida

People needed

250

Starts

2019-10-01

Expected to finish

2021-12-01

Last updated by the study team

2019-09-18

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Metabolic syndrome patients meeting 3 of 5 criteria:
• waist circumference (37 in) in white and AA men, (35 in) in Asian men, and (31.5 in) in women;
• triglycerides ≥150 mg/dl;
• high-density lipoprotein cholesterol (HDL-C) <40 mg/dl in men and <50 mg/dl in women;
• blood pressure ≥130/85 mm Hg
• fasting glucose ≥100 mg/d or HgbA1c ≥ 5.71 (includes diabetics)
• Patients requiring secondary ASCD prevention

You may not qualify if…

• Patients with less than 5 year survival
• Patients with cancer undergoing therapy or on palliative treatment
• Patients with end stage heart failure

Where it is running

• Internal Medicine Residency Clinic at Holy Cross Hospital — Fort Lauderdale, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.